Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Chlanda

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 8, 2024
T-cell specific in vivo gene delivery with DART-AAVs targeted to CD8Muhammed Burak Demircan, Luca J Zinser, Alexander Michels, et al.
Communications Biology|July 21, 2025
Inactivation of SARS-CoV-2 at acidic pH is driven by partial unfolding of spikeIrina Glas, Liv Zimmermann, Beiping Luo, et al.
Elife|January 22, 2024
Disulfide bridge-dependent dimerization triggers FGF2 membrane translocation into the extracellular spaceFabio Lolicato, Julia P Steringer, Roberto Saleppico, et al.
Cell Host & Microbe|April 1, 2023
IFITM3 blocks influenza virus entry by sorting lipids and stabilizing hemifusionSteffen Klein, Gonen Golani, Fabio Lolicato, et al.
Science Translational Medicine|July 29, 2020
A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samplesViet Loan Dao Thi, Konrad Herbst, Kathleen Boerner, et al.
Viruses|August 14, 2020
SARS-CoV-2 RNA Extraction Using Magnetic Beads for Rapid Large-Scale Testing by RT-qPCR and RT-LAMPSteffen Klein, Thorsten G Müller, Dina Khalid, et al.
Cell|October 5, 2023
SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9Nora Schmidt, Sabina Ganskih, Yuanjie Wei, et al.
Mbio|March 1, 2022
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication <i>In Vitro</i> and Decreases Viral Titers and Disease Progression in Syrian HamstersIart Luca Shytaj, Mohamed Fares, Lara Gallucci, et al.
Nature Communications|January 6, 2026
Sulfur-containing class of broad-spectrum antivirals improves influenza virus vaccine developmentDavid W Buchholz, Armando Pacheco, Sreetama Pal, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 8, 2024
T-cell specific in vivo gene delivery with DART-AAVs targeted to CD8Muhammed Burak Demircan, Luca J Zinser, Alexander Michels, et al.
Communications Biology|July 21, 2025
Inactivation of SARS-CoV-2 at acidic pH is driven by partial unfolding of spikeIrina Glas, Liv Zimmermann, Beiping Luo, et al.
Elife|January 22, 2024
Disulfide bridge-dependent dimerization triggers FGF2 membrane translocation into the extracellular spaceFabio Lolicato, Julia P Steringer, Roberto Saleppico, et al.
Cell Host & Microbe|April 1, 2023
IFITM3 blocks influenza virus entry by sorting lipids and stabilizing hemifusionSteffen Klein, Gonen Golani, Fabio Lolicato, et al.
Science Translational Medicine|July 29, 2020
A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samplesViet Loan Dao Thi, Konrad Herbst, Kathleen Boerner, et al.
Viruses|August 14, 2020
SARS-CoV-2 RNA Extraction Using Magnetic Beads for Rapid Large-Scale Testing by RT-qPCR and RT-LAMPSteffen Klein, Thorsten G Müller, Dina Khalid, et al.
Cell|October 5, 2023
SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9Nora Schmidt, Sabina Ganskih, Yuanjie Wei, et al.
Mbio|March 1, 2022
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication <i>In Vitro</i> and Decreases Viral Titers and Disease Progression in Syrian HamstersIart Luca Shytaj, Mohamed Fares, Lara Gallucci, et al.
Nature Communications|January 6, 2026
Sulfur-containing class of broad-spectrum antivirals improves influenza virus vaccine developmentDavid W Buchholz, Armando Pacheco, Sreetama Pal, et al.
Pageof 5